Urine-Based Genomic Test Identifies Hematuria Patients at High Risk for Bladder Cancer

Vesica Health’s (Irvine, CA, USA) AssureDx is a noninvasive urine test that assesses genomic changes related to bladder cancer, assisting in the identification of patients who would benefit from a clinical assessment by an urologist.